Copyright
©2011 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Clin Oncol. Mar 10, 2011; 2(3): 158-163
Published online Mar 10, 2011. doi: 10.5306/wjco.v2.i3.158
Published online Mar 10, 2011. doi: 10.5306/wjco.v2.i3.158
Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancers
Minoru Tada, Yousuke Nakai, Takashi Sasaki, Tsuyoshi Hamada, Rie Nagano, Dai Mohri, Koji Miyabayashi, Keisuke Yamamoto, Hirofumi Kogure, Kazumichi Kawakubo, Yukiko Ito, Natsuyo Yamamoto, Naoki Sasahira, Kenji Hirano, Hideaki Ijichi, Keishuke Tateishi, Hiroyuki Isayama, Kazuhiko Koike, Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan
Masao Omata, Yamanashi Prefectural Hospital Organization, 400-8506 Yamanashi, Japan
Author contributions: Tada M, Nakai Y, Sasaki T and Isayama H designed the research; Tada M, Nakai Y, Sasaki T, Hamada T, Nagano R, Mohri D, Miyabayashi K, Yamamoto K, Kogure H, Kawakubo K, Ito Y, Yamamoto N, Sasahira N, Hirano K and Isayama H performed the research; Tada M, Nakai Y, Sasaki T analyzed the data; Tada M, Ijichi H and Tateishi K contributed molecular interruption of chemotherapy; Omata M and Koike K supervised the research and Tada M wrote the paper.
Correspondence to: Minoru Tada, MD, Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655, Japan. mtada-tky@umin.ac.jp
Telephone: +81-3-38155411 Fax: +81-3-38140021
Received: December 14, 2010
Revised: January 27, 2011
Accepted: February 3, 2011
Published online: March 10, 2011
Revised: January 27, 2011
Accepted: February 3, 2011
Published online: March 10, 2011
Core Tip